pyrazinamide has been researched along with ascorbic acid in 12 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (25.00) | 18.7374 |
1990's | 1 (8.33) | 18.2507 |
2000's | 2 (16.67) | 29.6817 |
2010's | 5 (41.67) | 24.3611 |
2020's | 1 (8.33) | 2.80 |
Authors | Studies |
---|---|
González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
Ekins, S; Williams, AJ; Xu, JJ | 1 |
Bharate, SS; Vishwakarma, RA | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Agafonova, NA; Borisevich, SS; Burgart, YV; Chupakhin, ON; Evstigneeva, NP; Gerasimova, NA; Krasnykh, OP; Kungurov, NV; Kushch, SO; Makhaeva, GF; Maslova, VV; Rudakova, EV; Saloutin, VI; Shchegolkov, EV; Solodnikov, SY; Triandafilova, GA; Ulitko, MV; Zilberberg, NV | 1 |
Fox, IH; Gershon, SL; Stein, HB | 1 |
Fox, IH; Hasan, A; Stein, HB | 1 |
Donald, PR; Parkin, DP; Seifart, HI | 1 |
Borden, M; Kaufman, IA; Nyhan, WL; Stapleton, FB | 1 |
Saraswathy, SD; Shyamala Devi, CS | 1 |
1 review(s) available for pyrazinamide and ascorbic acid
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
11 other study(ies) available for pyrazinamide and ascorbic acid
Article | Year |
---|---|
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Thermodynamic equilibrium solubility measurements in simulated fluids by 96-well plate method in early drug discovery.
Topics: Drug Discovery; Pharmaceutical Preparations; Solubility; Thermodynamics | 2015 |
Multiple biological active 4-aminopyrazoles containing trifluoromethyl and their 4-nitroso-precursors: Synthesis and evaluation.
Topics: Animals; Bacteria; Drug Screening Assays, Antitumor; Epidermophyton; HeLa Cells; Humans; Mice; Microbial Sensitivity Tests; Molecular Structure; Nitroso Compounds; Pyrazoles; Rats, Sprague-Dawley; Structure-Activity Relationship; Trichophyton | 2020 |
Effects of vitamins on the renal handling of uric acid.
Topics: Ascorbic Acid; Blood Proteins; Glomerular Filtration Rate; Humans; Kidney; Kidney Tubules; Kinetics; Nicotinic Acids; Protein Binding; Pyrazinamide; Uric Acid | 1977 |
Ascorbic acid-induced uricosuria. A consequency of megavitamin therapy.
Topics: Ascorbic Acid; Aspirin; Female; Humans; Kidney; Kidney Calculi; Male; Models, Biological; Pyrazinamide; Uric Acid | 1976 |
Stability of isoniazid, rifampin and pyrazinamide in suspensions used for the treatment of tuberculosis in children.
Topics: Ascorbic Acid; Child; Chromatography, High Pressure Liquid; Drug Stability; Humans; Isoniazid; Pyrazinamide; Rifampin; Suspensions; Temperature; Tuberculosis | 1991 |
Renal pathogenesis of familial hyperuricemia: studies in two kindreds.
Topics: Adolescent; Ascorbic Acid; Humans; Kidney; Kidney Tubules; Male; Probenecid; Protein Binding; Purine-Pyrimidine Metabolism, Inborn Errors; Pyrazinamide; Uric Acid | 1981 |
Modulating effect of Liv.100, an ayurvedic formulation on antituberculosis drug-induced alterations in rat liver microsomes.
Topics: Animals; Antitubercular Agents; Ascorbic Acid; Cytochrome b Group; Cytochrome P-450 Enzyme System; Cytochrome Reductases; Cytochrome-B(5) Reductase; Drug Interactions; Glucose-6-Phosphatase; Herbal Medicine; India; Isoniazid; Lipid Peroxidation; Magnoliopsida; Male; Medicine, Ayurvedic; Microsomes, Liver; NADPH-Ferrihemoprotein Reductase; Phytotherapy; Plant Extracts; Plants, Medicinal; Protective Agents; Pyrazinamide; Rats; Rats, Wistar; Rifampin | 2001 |